Operating Lease, Right-of-Use Asset of BIO-TECHNE Corp from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BIO-TECHNE Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • BIO-TECHNE Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $70,725,000, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $70,725,000 -$18,496,000 -21% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $73,399,000 -$17,886,000 -20% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $83,744,000 -$13,514,000 -14% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $85,383,000 -$15,480,000 -15% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $89,221,000 -$13,056,000 -13% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $91,285,000 -$7,041,000 -7.2% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $97,258,000 -$718,000 -0.73% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $100,863,000 +$16,926,000 +20% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $102,277,000 +$32,532,000 +47% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $98,326,000 +$32,770,000 +50% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $97,976,000 +$34,526,000 +54% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $83,937,000 +$19,644,000 +31% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $69,745,000 -$1,651,000 -2.3% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $65,556,000 -$8,278,000 -11% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $63,450,000 -$8,380,000 -12% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $64,293,000 -$3,861,000 -5.7% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $71,396,000 +$1,378,000 +2% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $73,834,000 +$2,369,000 +3.3% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $71,830,000 -$1,921,000 -2.6% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $68,154,000 -$7,670,000 -10% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $70,018,000 -$6,944,000 -9% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $71,465,000 +$71,465,000 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $73,751,000 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $75,824,000 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $76,962,000 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $0 30 Jun 2019 10-K 26 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.